FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1773-1780 June 6, 2002 Number 23 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Perspective by Curfman, G. D. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Sharma, S. PubMed Citation

ABSTRACT

Background The need for repeated treatment of restenosis of a treated vessel remains the main limitation of percutaneous coronary revascularization. Because sirolimus (rapamycin) inhibits the proliferation of lymphocytes and smooth-muscle cells, we compared a sirolimus-eluting stent with a standard uncoated stent in patients with angina pectoris.

Methods We performed a randomized, double-blind trial to compare the two types of stents for revascularization of single, primary lesions in native coronary arteries. The trial included 238 patients at 19 medical centers. The primary end point was in-stent late luminal loss (the difference between the minimal luminal diameter immediately after the procedure and the diameter at six months). Secondary end points included the percentage of in-stent stenosis of the luminal diameter and the rate of restenosis (luminal narrowing of 50 percent or more). We also analyzed a composite clinical end point consisting of death, myocardial infarction, and percutaneous or surgical revascularization at 1, 6, and 12 months.

Results At six months, the degree of neointimal proliferation, manifested as the mean (±SD) late luminal loss, was significantly lower in the sirolimus-stent group (–0.01±0.33 mm) than in the standard-stent group (0.80±0.53 mm, P<0.001). None of the patients in the sirolimus-stent group, as compared with 26.6 percent of those in the standard-stent group, had restenosis of 50 percent or more of the luminal diameter (P<0.001). There were no episodes of stent thrombosis. During a follow-up period of up to one year, the overall rate of major cardiac events was 5.8 percent in the sirolimus-stent group and 28.8 percent in the standard-stent group (P<0.001). The difference was due entirely to a higher rate of revascularization of the target vessel in the standard-stent group.

Conclusions As compared with a standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis, and associated clinical events.

Source Information

From Institut Cardiovasculaire Paris Sud, Massy, France (M.-C.M.); Thoraxcentrum, Rotterdam, the Netherlands (P.W.S.); Institute Dante Pazzanese de Cardiologia, São Paulo, Brazil (J.E.S.); Clinique Pasteur, Toulouse, France (J.F.); Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico (E.B.H.); the Heart Institute of the University of São Paulo, São Paulo, Brazil (M.P.); Centro Cuore Columbus, Milan, Italy (A.C.); Herzzentrum, Leipzig, Germany (G.S.); Centre Hospitalier Privé Beauregard, Marseilles, France (P.B.); Azienda Ospedaliera Ospedali Riuniti di Bergamo, Bergamo, Italy (G.G.); Semmelweis Egyetem Egészégtudomanyi Kar, Budapest, Hungary (F.M.); and Cordis, Johnson & Johnson, Warren, N.J. (R.F.).

Address reprint requests to Dr. Morice at the Institut Hospitalier Jacques Cartier, Ave. du Noyer Lambert, 91300 Massy, France.

Full Text of this Article

Related Letters:

Sirolimus-Eluting Coronary Stents
Sharma S., Bhambi B., Nyitray W., Morice M.-C.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:1285, Oct 17, 2002. Correspondence

This article has been cited by other articles:

• Beijk, M. A.M., Klomp, M., Verouden, N. J.W., van Geloven, N., Koch, K. T., Henriques, J. P.S., Baan, J., Vis, M. M., Scheunhage, E., Piek, J. J., Tijssen, J. G.P., de Winter, R. J. (2009). GenousTM endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. Eur Heart J 0: ehp476v1-ehp476 [Abstract] [Full Text]  
• Hecht, H. S., Polena, S., Jelnin, V., Jimenez, M., Bhatti, T., Parikh, M., Panagopoulos, G., Roubin, G. (2009). Stent gap by 64-detector computed tomographic angiography relationship to in-stent restenosis, fracture, and overlap failure.. J Am Coll Cardiol 54: 1949-1959 [Abstract] [Full Text]  
• Silvestri, D., Cristallini, C., Gagliardi, M., Barbani, N., D'Acunto, M., Ciardelli, G., Giusti, P. (2009). Acrylic Copolymers as Candidates for Drug-Eluting Coating of Vascular Stents. J Biomater Appl 24: 353-383 [Abstract]  
• Hoppmann, P., Erl, A., Turk, S., Tiroch, K., Mehilli, J., Schomig, A., Kastrati, A., Koch, W. (2009). No Association of Chromosome 9p21.3 Variation With Clinical and Angiographic Outcomes After Placement of Drug-Eluting Stents. J Am Coll Cardiol Intv 2: 1149-1155 [Abstract] [Full Text]  
• Zhang, F, Dong, L, Ge, J (2009). Simple versus complex stenting strategy for coronary artery bifurcation lesions in the drug-eluting stent era: a meta-analysis of randomised trials. Heart 95: 1676-1681 [Abstract] [Full Text]  
• Meredith, I. T., Worthley, S., Whitbourn, R., Walters, D. L., McClean, D., Horrigan, M., Popma, J. J., Cutlip, D. E., DePaoli, A., Negoita, M., Fitzgerald, P. J., for the RESOLUTE Investigators, (2009). Clinical and Angiographic Results With the Next-Generation Resolute Stent System: A Prospective, Multicenter, First-in-Human Trial. J Am Coll Cardiol Intv 2: 977-985 [Abstract] [Full Text]  
• Sera, F., Awata, M., Uematsu, M., Kotani, J.-i., Nanto, S., Nagata, S. (2009). Optimal Stent-Sizing With Intravascular Ultrasound Contributes to Complete Neointimal Coverage After Sirolimus-Eluting Stent Implantation Assessed by Angioscopy. J Am Coll Cardiol Intv 2: 989-994 [Abstract] [Full Text]  
• Harjai, K J, Shenoy, C, Orshaw, P, Boura, J (2009). Dual antiplatelet therapy for more than 12 months after percutaneous coronary intervention: insights from the Guthrie PCI Registry. Heart 95: 1579-1586 [Abstract] [Full Text]  
• Sanada, F., Taniyama, Y., Iekushi, K., Azuma, J., Okayama, K., Kusunoki, H., Koibuchi, N., Doi, T., Aizawa, Y., Morishita, R. (2009). Negative Action of Hepatocyte Growth Factor/c-Met System on Angiotensin II Signaling via Ligand-Dependent Epithelial Growth Factor Receptor Degradation Mechanism in Vascular Smooth Muscle Cells. Circ. Res. 105: 667-675 [Abstract] [Full Text]  
• Caixeta, A., Leon, M. B., Lansky, A. J., Nikolsky, E., Aoki, J., Moses, J. W., Schofer, J., Morice, M.-C., Schampaert, E., Kirtane, A. J., Popma, J. J., Parise, H., Fahy, M., Mehran, R. (2009). 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.. J Am Coll Cardiol 54: 894-902 [Abstract] [Full Text]  
• Curtis, J. P., Schreiner, G., Wang, Y., Chen, J., Spertus, J. A., Rumsfeld, J. S., Brindis, R. G., Krumholz, H. M. (2009). All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients.. J Am Coll Cardiol 54: 903-907 [Abstract] [Full Text]  
• Menozzi, A., Solinas, E., Ortolani, P., Repetto, A., Saia, F., Piovaccari, G., Manari, A., Magagnini, E., Vignali, L., Bonizzoni, E., Merlini, P. A., Cavallini, C., Ardissino, D., for the SES-SMART Investigators, (2009). Twenty-four months clinical outcomes of sirolimus-eluting stents for the treatment of small coronary arteries: the long-term SES-SMART clinical study. Eur Heart J 30: 2095-2101 [Abstract] [Full Text]  
• Herdeg, C., Gohring-Frischholz, K., Haase, K. K., Geisler, T., Zurn, C., Hartmann, U., Wohrle, J., Nusser, T., Dippon, J., May, A. E., Gawaz, M. (2009). Catheter-Based Delivery of Fluid Paclitaxel for Prevention of Restenosis in Native Coronary Artery Lesions After Stent Implantation. Circ Cardiovasc Interv 2: 294-301 [Abstract] [Full Text]  
• Onuma, Y., Kukreja, N., Piazza, N., Eindhoven, J., Girasis, C., Schenkeveld, L., van Domburg, R., Serruys, P. W., Interventional Cardiologists of the Thoraxcenter (, (2009). The Everolimus-Eluting Stent in Real-World Patients: 6-Month Follow-Up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) Registry. J Am Coll Cardiol 54: 269-276 [Abstract] [Full Text]  
• Kaneda, H, Shiono, T, Miyashita, Y, Takahashi, S, Taketani, Y, Domae, H, Matsumi, J, Mizuno, S, Minami, Y, Sugitatsu, K, Saito, S (2009). Efficacy and safety of pioglitazone in patients with ST elevation myocardial infarction treated with primary stent implantation. Heart 95: 1079-1084 [Abstract] [Full Text]  
• Wilson, J M (2009). Diagnosis and treatment of acquired coronary artery disease in adults. Postgrad. Med. J. 85: 364-365 [Abstract] [Full Text]  
• Camici, G. G., Steffel, J., Amanovic, I., Breitenstein, A., Baldinger, J., Keller, S., Luscher, T. F., Tanner, F. C. (2009). Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. Eur Heart J 0: ehp259v1-ehp259 [Abstract] [Full Text]  
• Thiele, H., Neumann-Schniedewind, P., Jacobs, S., Boudriot, E., Walther, T., Mohr, F.-W., Schuler, G., Falk, V. (2009). Randomized Comparison of Minimally Invasive Direct Coronary Artery Bypass Surgery Versus Sirolimus-Eluting Stenting in Isolated Proximal Left Anterior Descending Coronary Artery Stenosis. J Am Coll Cardiol 53: 2324-2331 [Abstract] [Full Text]  
• Alfonso, F., Perez-Vizcayno, M.-J., Ruiz, M., Suarez, A., Cazares, M., Hernandez, R., Escaned, J., Banuelos, C., Jimenez-Quevedo, P., Macaya, C. (2009). Coronary aneurysms after drug-eluting stent implantation clinical, angiographic, and intravascular ultrasound findings.. J Am Coll Cardiol 53: 2053-2060 [Abstract] [Full Text]  
• Ormiston, J. A., Serruys, P. W.S. (2009). Bioabsorbable Coronary Stents. Circ Cardiovasc Interv 2: 255-260 [Full Text]  
• Takagi, T., Okura, H., Kobayashi, Y., Kataoka, T., Taguchi, H., Toda, I., Tamita, K., Yamamuro, A., Sakanoue, Y., Ito, A., Yanagi, S., Shimeno, K., Waseda, K., Yamasaki, M., Fitzgerald, P. J., Ikeno, F., Honda, Y., Yoshiyama, M., Yoshikawa, J., for the POPPS Investigators, (2009). A Prospective, Multicenter, Randomized Trial to Assess Efficacy of Pioglitazone on In-Stent Neointimal Suppression in Type 2 Diabetes: POPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study). J Am Coll Cardiol Intv 2: 524-531 [Abstract] [Full Text]  
• Chevalier, B., Silber, S., Park, S.-J., Garcia, E., Schuler, G., Suryapranata, H., Koolen, J., Hauptmann, K. E., Wijns, W., Morice, M.-C., Carrie, D., van Es, G.-A., Nagai, H., Detiege, D., Paunovic, D., Serruys, P. W., for the NOBORI 1 Clinical Investigators, (2009). Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberte Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries: The NOBORI 1 Trial--Phase 2. Circ Cardiovasc Interv 2: 188-195 [Abstract] [Full Text]  
• Vaquerizo, B., Lefevre, T., Darremont, O., Silvestri, M., Louvard, Y., Leymarie, J. L., Garot, P., Routledge, H., de Marco, F., Unterseeh, T., Zwahlen, M., Morice, M.-C. (2009). Unprotected Left Main Stenting in the Real World: Two-Year Outcomes of the French Left Main Taxus Registry. Circulation 119: 2349-2356 [Abstract] [Full Text]  
• Higo, T., Ueda, Y., Oyabu, J., Okada, K., Nishio, M., Hirata, A., Kashiwase, K., Ogasawara, N., Hirotani, S., Kodama, K. (2009). Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent an angioscopic study.. J Am Coll Cardiol Img 2: 616-624 [Abstract] [Full Text]  
• Suzuki, Y., Yeung, A. C., Ikeno, F. (2009). The Pre-Clinical Animal Model in the Translational Research of Interventional Cardiology. J Am Coll Cardiol Intv 2: 373-383 [Abstract] [Full Text]  
• Costa, J. R. Jr, Abizaid, A., Costa, R., Feres, F., Tanajura, L. F., Abizaid, A., Maldonado, G., Staico, R., Siqueira, D., Sousa, A. G.M.R., Bonan, R., Sousa, J. E. (2009). 1-Year Results of the Hydroxyapatite Polymer-Free Sirolimus-Eluting Stent for the Treatment of Single De Novo Coronary Lesions: The VESTASYNC I Trial. J Am Coll Cardiol Intv 2: 422-427 [Abstract] [Full Text]  
• Liu, X., Doi, H., Maehara, A., Mintz, G. S., de Ribamar Costa, J. Jr, Sano, K., Weisz, G., Dangas, G. D., Lansky, A. J., Kreps, E. M., Collins, M., Fahy, M., Stone, G. W., Moses, J. W., Leon, M. B., Mehran, R. (2009). A Volumetric Intravascular Ultrasound Comparison of Early Drug-Eluting Stent Thrombosis Versus Restenosis. J Am Coll Cardiol Intv 2: 428-434 [Abstract] [Full Text]  
• Weisz, G., Leon, M. B., Holmes, D. R. Jr, Kereiakes, D. J., Popma, J. J., Teirstein, P. S., Cohen, S. A., Wang, H., Cutlip, D. E., Moses, J. W. (2009). Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.. J Am Coll Cardiol 53: 1488-1497 [Abstract] [Full Text]  
• Lee, K.-J., Hinek, A., Chaturvedi, R. R., Almeida, C. L., Honjo, O., Koren, G., Benson, L. N. (2009). Rapamycin-Eluting Stents in the Arterial Duct: Experimental Observations in the Pig Model. Circulation 119: 2078-2085 [Abstract] [Full Text]  
• Li, Y., Zheng, Z., Xu, B., Zhang, S., Li, W., Gao, R., Hu, S. (2009). Comparison of Drug-Eluting Stents and Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Disease: Three-Year Follow-Up Results From a Single Institution. Circulation 119: 2040-2050 [Abstract] [Full Text]  
• Byrne, R. A., Mehilli, J., Iijima, R., Schulz, S., Pache, J., Seyfarth, M., Schomig, A., Kastrati, A., for the Intracoronary Stenting and Angiographic Re, (2009). A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents. Eur Heart J 30: 923-931 [Abstract] [Full Text]  
• Ruiz-Nodar, J. M., Marin, F., Sanchez-Paya, J., Hurtado, J. A., Valencia-Martin, J., Manzano-Fernandez, S., Roldan, V., Perez-Andreu, V., Sogorb, F., Valdes, M., Lip, G. Y.H. (2009). Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation. Eur Heart J 30: 932-939 [Abstract] [Full Text]  
• Steinhubl, S. R., Berger, P. B. (2009). Aspirin following PCI: too much of a good thing?. Eur Heart J 30: 882-884 [Full Text]  
• Birim, O., van Gameren, M., Bogers, A. J.J.C., Serruys, P. W., Mohr, F. W., Kappetein, A. P. (2009). Complexity of Coronary Vasculature Predicts Outcome of Surgery for Left Main Disease. Ann. Thorac. Surg. 87: 1097-1105 [Abstract] [Full Text]  
• Qiangjun Cai, , Skelding, K., Armstrong, A. Jr, Desai, D., Wood, G. C., Blankenship, J. (2009). Predictors of Long-Term Major Adverse Cardiac Events and Clinical Restenosis Following Elective Percutaneous Coronary Stenting. ANGIOLOGY 60: 141-147 [Abstract]  
• Byrne, R. A., Iijima, R., Mehilli, J., Pinieck, S., Bruskina, O., Schomig, A., Kastrati, A. (2009). Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent Polymer. J Am Coll Cardiol Intv 2: 291-299 [Abstract] [Full Text]  
• Han, Y., Jing, Q., Xu, B., Yang, L., Liu, H., Shang, X., Jiang, T., Li, Z., Zhang, H., Li, H., Qiu, J., Liu, Y., Li, Y., Chen, X., Gao, R., for the CREATE (Multi-Center Registry of Excel Bio, (2009). Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in "Real-World" Practice: 18-Month Clinical and 9-Month Angiographic Outcomes. J Am Coll Cardiol Intv 2: 303-309 [Abstract] [Full Text]  
• Waksman, R., Erbel, R., Di Mario, C., Bartunek, J., de Bruyne, B., Eberli, F. R., Erne, P., Haude, M., Horrigan, M., Ilsley, C., Bose, D., Bonnier, H., Koolen, J., Luscher, T. F., Weissman, N. J., on behalf of the PROGRESS-AMS (Clinical Performanc, (2009). Early- and Long-Term Intravascular Ultrasound and Angiographic Findings After Bioabsorbable Magnesium Stent Implantation in Human Coronary Arteries. J Am Coll Cardiol Intv 2: 312-320 [Abstract] [Full Text]  
• Tamburino, C., La Manna, A., Di Salvo, M. E., Sacchetta, G., Capodanno, D., Mehran, R., Dangas, G., Corcos, T., Prati, F. (2009). First-in-Man 1-Year Clinical Outcomes of the Catania Coronary Stent System With Nanothin Polyzene-F in De Novo Native Coronary Artery Lesions: The ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) Trial. J Am Coll Cardiol Intv 2: 197-204 [Abstract] [Full Text]  
• Pendyala, L. K., Li, J., Shinke, T., Geva, S., Yin, X., Chen, J. P., King, S. B. III, Robinson, K. A., Chronos, N. A.F., Hou, D. (2009). Endothelium-Dependent Vasomotor Dysfunction in Pig Coronary Arteries With Paclitaxel-Eluting Stents Is Associated With Inflammation and Oxidative Stress. J Am Coll Cardiol Intv 2: 253-262 [Abstract] [Full Text]  
• Kaltoft, A., Jensen, L. O., Maeng, M., Tilsted, H. H., Thayssen, P., Bottcher, M., Lassen, J. F., Krusell, L. R., Rasmussen, K., Hansen, K. N., Pedersen, L., Johnsen, S. P., Sorensen, H. T., Thuesen, L. (2009). 2-Year Clinical Outcomes After Implantation of Sirolimus-Eluting, Paclitaxel-Eluting, and Bare-Metal Coronary Stents Results From the WDHR (Western Denmark Heart Registry).. J Am Coll Cardiol 53: 658-664 [Abstract] [Full Text]  
• Teirstein, P. S. (2009). Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis. Circulation 119: 1021-1033 [Full Text]  
• van Werkum, J. W., Heestermans, A. A.C.M., de Korte, F. I., Kelder, J. C., Suttorp, M.-J., Rensing, B. J.W.M., Zwart, B., Brueren, B. R. G., Koolen, J. J., Dambrink, J.-H. E., van't Hof, A. W.J., Verheugt, F. W.A., ten Berg, J. M. (2009). Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis: An Analysis of 431 Cases. Circulation 119: 828-834 [Abstract] [Full Text]  
• (2009). Randomized Comparison of Coronary Bifurcation Stenting With the Crush Versus the Culotte Technique Using Sirolimus Eluting Stents: The Nordic Stent Technique Study. Circ Cardiovasc Interv 2: 27-34  
• Hassan, A. K.M., Bergheanu, S. C., Stijnen, T., van der Hoeven, B. L., Snoep, J. D., Plevier, J. W.M., Schalij, M. J., Jukema, J. W. (2009). Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J 0: ehn553v1-9 [Abstract] [Full Text]  
• Philpott, A. C. MD, Southern, D. A. MSc, Clement, F. M. PhD, Galbraith, P. D. BN MSc, Traboulsi, M. MD, Knudtson, M. L. MD, Ghali, W. A. MD, for the APPROACH Investigators, (2009). Long-term outcomes of patients receiving drug-eluting stents. CMAJ 180: 167-174 [Abstract] [Full Text]  
• Authors/writing members:, , Daemen, J., Simoons, M. L., Wijns, W., Bagust, A., Bos, G., Bowen, J. M., Braunwald, E., Camenzind, E., Chevalier, B., DiMario, C., Fajadet, J., Gitt, A., Guagliumi, G., Hillege, H. L., James, S., Juni, P., Kastrati, A., Kloth, S., Kristensen, S. D., Krucoff, M., Legrand, V., Pfisterer, M., Rothman, M., Serruys, P. W., Silber, S., Steg, P. G., Tariah, I., Wallentin, L., Windecker, S. W., Participants in the Forum:, , Aimonetti, A., Allocco, D., Baczynska, A., Bagust, A., Berenger, M., Bos, G., Boam, A., Bowen, J.M., Braunwald, E., Calle, J.P., Camenzind, E., Campo, G., Carlier, S., Chevalier, B., Daemen, J., de Schepper, J., Di Bisceglie, G., DiMario, C., Dobbels, H., Fajadet, J., Farb, A., Ghislain, J.C., Gitt, A., Guagliumi, G., Hellbardt, S., Hillege, H.L., ten Hoedt, R., Isaia, C., James, S., de Jong, P., Juni, P., Kastrati, A., Klasen, E., Kloth, S., Kristensen, S.D., Krucoff, M., Legrand, V., Lekehal, M., LeNarz, L., Ni Mhullain, F., Nagai, H., Patteet, A., Paunovic, D., Pfisterer, M., Potgieter, A., Purdy, I., Raveau-Landon, C., Rothman, M., Serruys, P.W., Silber, S., Simoons, M.L., Steg, P.G., Tariah, I., Ternstrom, S., Van Wuytswinkel, J., Waliszewski, M., Wallentin, L., Wijns, W., Windecker, S.W. (2009). Meeting Report: ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. Eur Heart J 30: 152-161 [Full Text]  
• Chen, J. P., Crisco, L. V., Jabara, R., King, S. B. III (2009). Late Angiographic Stent Thrombosis: The LAST Straw for Drug-Eluting Stents?. ANGIOLOGY 59: 667-675 [Abstract]  
• Park, S.-J., Kim, Y.-H. (2008). Current Status of Percutaneous Coronary Intervention With Drug-Eluting Stents in Asia. Circulation 118: 2730-2737 [Full Text]  
• Colombo, A., Gerber, R. T. (2008). Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual Antiplatelet Therapy After Drug-Eluting Stents Should Not Be Continued for More Than 1 Year and Preferably Indefinitely. Circ Cardiovasc Interv 1: 226-232 [Full Text]  
• Lee, M. S., Kobashigawa, J., Tobis, J. (2008). Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft Vasculopathy. J Am Coll Cardiol Intv 1: 710-715 [Abstract] [Full Text]  
• Marsboom, G., Archer, S. L. (2008). Pathways of Proliferation: New Targets to Inhibit the Growth of Vascular Smooth Muscle Cells. Circ. Res. 103: 1047-1049 [Full Text]  
• Firth, B. G., Cooper, L. M., Fearn, S. (2008). The Appropriate Role Of Cost-Effectiveness In Determining Device Coverage: A Case Study Of Drug-Eluting Stents. Health Aff (Millwood) 27: 1577-1586 [Abstract] [Full Text]  
• Mehilli, J., Byrne, R. A., Wieczorek, A., Iijima, R., Schulz, S., Bruskina, O., Pache, J., Wessely, R., Schomig, A., Kastrati, A., for the Intracoronary Stenting and Angiographic Re, (2008). Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. Eur Heart J 29: 1975-1982 [Abstract] [Full Text]  
• Takano, M., Yamamoto, M., Murakami, D., Inami, S., Okamatsu, K., Seimiya, K., Ohba, T., Seino, Y., Mizuno, K. (2008). Lack of Association Between Large Angiographic Late Loss and Low Risk of In-Stent Thrombus: Angioscopic Comparison Between Paclitaxel- and Sirolimus-Eluting Stents. Circ Cardiovasc Interv 1: 20-27 [Abstract] [Full Text]  
• Austin, D., Oldroyd, K. G., McConnachie, A., Slack, R., Eteiba, H., Flapan, A. D., Jennings, K. P., Northcote, R. J., Pell, A. C.H., Starkey, I. R., Pell, J. P. (2008). Drug-Eluting Stents Versus Bare-Metal Stents for Off-Label Indications: A Propensity Score-Matched Outcome Study. Circ Cardiovasc Interv 1: 45-52 [Abstract] [Full Text]  
• Shaoliang Chen, , Junjie Zhang, , Fei Ye, , Zhongsheng Zhu, , Song Lin, , Nailiang Tian, , Zhizhong Liu, , Weiyi Fang, , Yundai Chen, , Xuewen Sun, , Kwan, T. W. (2008). Crush Stenting With Paclitaxel-Eluting or Sirolimus-Eluting Stents for the Treatment of Coronary Bifurcation Lesions. ANGIOLOGY 59: 475-483 [Abstract]  
• Newsome, L. T., Kutcher, M. A., Royster, R. L. (2008). Coronary Artery Stents: Part I. Evolution of Percutaneous Coronary Intervention. Anesth. Analg. 107: 552-569 [Abstract] [Full Text]  
• Booth, J., Clayton, T., Pepper, J., Nugara, F., Flather, M., Sigwart, U., Stables, R. H., on Behalf of the SoS Investigators, (2008). Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: Six-Year Follow-Up From the Stent or Surgery Trial (SoS). Circulation 118: 381-388 [Abstract] [Full Text]  
• Ishii, H., Kumada, Y., Toriyama, T., Aoyama, T., Takahashi, H., Yamada, S., Yasuda, Y., Yuzawa, Y., Maruyama, S., Matsuo, S., Matsubara, T., Murohara, T. (2008). Cilostazol Improves Long-Term Patency after Percutaneous Transluminal Angioplasty in Hemodialysis Patients with Peripheral Artery Disease. CJASN 3: 1034-1040 [Abstract] [Full Text]  
• Meliga, E., Garcia-Garcia, H. M., Valgimigli, M., Chieffo, A., Biondi-Zoccai, G., Maree, A. O., Cook, S., Reardon, L., Moretti, C., De Servi, S., Palacios, I. F., Windecker, S., Colombo, A., van Domburg, R., Sheiban, I., Serruys, P. W. (2008). Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.. J Am Coll Cardiol 51: 2212-2219 [Abstract] [Full Text]  
• Ishii, Y., Sakamoto, S.-i., Kronengold, R. T., Virmani, R., Rivera, E. A., Goldman, S. M., Prechtel, E. J., Hill, J. G., Damiano, R. J. Jr. (2008). A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: Excellent 6-month patency.. J. Thorac. Cardiovasc. Surg. 135: 1237-1246 [Abstract] [Full Text]  
• Sobel, M., Verhaeghe, R. (2008). Antithrombotic Therapy for Peripheral Artery Occlusive Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 815S-843S [Abstract] [Full Text]  
• Barilli, A., Visigalli, R., Sala, R., Gazzola, G. C., Parolari, A., Tremoli, E., Bonomini, S., Simon, A., Closs, E. I., Dall'Asta, V., Bussolati, O. (2008). In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function. Cardiovasc Res 78: 563-571 [Abstract] [Full Text]  
• Groeneveld, P. W., Matta, M. A., Greenhut, A. P., Yang, F. (2008). Drug-Eluting Compared With Bare-Metal Coronary Stents Among Elderly Patients. J Am Coll Cardiol 51: 2017-2024 [Abstract] [Full Text]  
• Bhatt, S. H, Hauser, T. H (2008). Very Late Stent Thrombosis After Dual Antiplatelet Therapy Discontinuation in a Patient with a History of Acute Stent Thrombosis. The Annals of Pharmacotherapy 42: 708-712 [Abstract] [Full Text]  
• Hannan, E. L., Racz, M., Holmes, D. R., Walford, G., Sharma, S., Katz, S., Jones, R. H., King, S. B. III (2008). Comparison of Coronary Artery Stenting Outcomes in the Eras Before and After the Introduction of Drug-Eluting Stents. Circulation 117: 2071-2078 [Abstract] [Full Text]  
• Raja, S. G, Dreyfus, G. D (2008). Current Status of Off-pump Coronary Artery Bypass Surgery. Asian Cardiovasc. Thorac. Ann. 16: 164-178 [Abstract] [Full Text]  
• Ricciardi, R., Virnig, B. A., Ogilvie, J. W. Jr, Dahlberg, P. S., Selker, H. P., Baxter, N. N. (2008). Volume-Outcome Relationship for Coronary Artery Bypass Grafting in an Era of Decreasing Volume. Arch Surg 143: 338-344 [Abstract] [Full Text]  
• Hannan, E. L., Racz, M., Walford, G., Holmes, D. R., Jones, R. H., Sharma, S., Katz, S., King, S. B. III (2008). Drug-Eluting Versus Bare-Metal Stents in the Treatment of Patients With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol Intv 1: 129-135 [Abstract] [Full Text]  
• van der Hoeven, B. L., Liem, S.-S., Dijkstra, J., Bergheanu, S. C., Putter, H., Antoni, M. L., Atsma, D. E., Bootsma, M., Zeppenfeld, K., Jukema, J. W., Schalij, M. J. (2008). Stent Malapposition After Sirolimus-Eluting and Bare-Metal Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction: Acute and 9-Month Intravascular Ultrasound Results of the MISSION! Intervention Study. J Am Coll Cardiol Intv 1: 192-201 [Abstract] [Full Text]  
• Cheng, C., Tempel, D., Oostlander, A., Helderman, F., Gijsen, F., Wentzel, J., van Haperen, R., Haitsma, D. B., Serruys, P. W., van der Steen, A. F.W., de Crom, R., Krams, R. (2008). Rapamycin modulates the eNOS vs. shear stress relationship. Cardiovasc Res 78: 123-129 [Abstract] [Full Text]  
• Pinto Slottow, T. L., Waksman, R. (2008). Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel Meeting on the Endeavor Zotarolimus-Eluting Coronary Stent. Circulation 117: 1603-1608 [Full Text]  
• Billinger, M., Beutler, J., Taghetchian, K. R., Remondino, A., Wenaweser, P., Cook, S., Togni, M., Seiler, C., Stettler, C., Eberli, F. R., Luscher, T. F., Wandel, S., Juni, P., Meier, B., Windecker, S. (2008). Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients. Eur Heart J 29: 718-725 [Abstract] [Full Text]  
• Abraham, N. G., Kappas, A. (2008). Pharmacological and Clinical Aspects of Heme Oxygenase. Pharmacol. Rev. 60: 79-127 [Abstract] [Full Text]  
• Hoffmann, R, Morice, M-C, Moses, J W, Fitzgerald, P J, Mauri, L, Breithardt, G, Schofer, J, Serruys, P W, Stoll, H-P, Leon, M B (2008). Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials. Heart 94: 322-328 [Abstract] [Full Text]  
• Kip, K. E., Hollabaugh, K., Marroquin, O. C., Williams, D. O. (2008). The Problem With Composite End Points in Cardiovascular Studies The Story of Major Adverse Cardiac Events and Percutaneous Coronary Intervention.. J Am Coll Cardiol 51: 701-707 [Abstract] [Full Text]  
• van der Hoeven, B. L., Liem, S.-S., Jukema, J. W., Suraphakdee, N., Putter, H., Dijkstra, J., Atsma, D. E., Bootsma, M., Zeppenfeld, K., Oemrawsingh, P. V., van der Wall, E. E., Schalij, M. J. (2008). Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study.. J Am Coll Cardiol 51: 618-626 [Abstract] [Full Text]  
• Jeremias, A., Kirtane, A. (2008). Balancing Efficacy and Safety of Drug-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention. ANN INTERN MED 148: 234-238 [Abstract] [Full Text]  
• Teirstein, P. S. (2008). Unprotected left main intervention patient selection, operator technique, and clinical outcomes.. J Am Coll Cardiol Intv 1: 5-13 [Abstract] [Full Text]  
• Melikian, N, Wijns, W (2008). Drug-eluting stents: a critique. Heart 94: 145-152 [Abstract] [Full Text]  
• Romagnoli, E., Sangiorgi, G. M., Cosgrave, J., Guillet, E., Colombo, A. (2008). Drug-eluting stenting the case for post-dilation.. J Am Coll Cardiol Intv 1: 22-31 [Abstract] [Full Text]  
• Rogacka, R., Chieffo, A., Michev, I., Airoldi, F., Latib, A., Cosgrave, J., Montorfano, M., Carlino, M., Sangiorgi, G. M., Castelli, A., Godino, C., Magni, V., Aranzulla, T. C., Romagnoli, E., Colombo, A. (2008). Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation.. J Am Coll Cardiol Intv 1: 56-61 [Abstract] [Full Text]  
• Hannan, E. L., Wu, C., Walford, G., Culliford, A. T., Gold, J. P., Smith, C. R., Higgins, R. S.D., Carlson, R. E., Jones, R. H. (2008). Drug-Eluting Stents vs. Coronary-Artery Bypass Grafting in Multivessel Coronary Disease. NEJM 358: 331-341 [Abstract] [Full Text]  
• Marroquin, O. C., Selzer, F., Mulukutla, S. R., Williams, D. O., Vlachos, H. A., Wilensky, R. L., Tanguay, J.-F., Holper, E. M., Abbott, J. D., Lee, J. S., Smith, C., Anderson, W. D., Kelsey, S. F., Kip, K. E. (2008). A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications. NEJM 358: 342-352 [Abstract] [Full Text]  
• American College of Cardiology/American Heart Asso, , 2007 Writing Group to Review New Evidence and Upda, , King, S. B. III, Smith, S. C. Jr, Hirshfeld, J. W. Jr, Jacobs, A. K., Morrison, D. A., Williams, D. O. (2008). 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention. J Am Coll Cardiol 51: 172-209 [Full Text]  
• King, S. B. III, Smith, S. C. Jr, Hirshfeld, J. W. Jr, Jacobs, A. K., Morrison, D. A., Williams, D. O., 2005 WRITING COMMITTEE MEMBERS, , Smith, S. C. Jr, Feldman, T. E., Hirshfeld, J. W. Jr, Jacobs, A. K., Kern, M. J., King, S. B. III, Morrison, D. A., O'Neill, W. W., Schaff, H. V., Whitlow, P. L., Williams, D. O., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Buller, C. E., Creager, M. A., Ettinger, S. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B., Tarkington, L. G., Yancy, C. W. (2008). 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 117: 261-295 [Full Text]  
• Pocock, S. J., Lansky, A. J., Mehran, R., Popma, J. J., Fahy, M. P., Na, Y., Dangas, G., Moses, J. W., Pucelikova, T., Kandzari, D. E., Ellis, S. G., Leon, M. B., Stone, G. W. (2008). Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials.. J Am Coll Cardiol 51: 23-32 [Abstract] [Full Text]